[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.197.142.219. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Citations 0
Health Agencies Update
January 27, 2010

Clopidogrel Interaction

JAMA. 2010;303(4):322. doi:10.1001/jama.2009.1982

Omeprazole, a proton pump inhibitor, may hamper the effectiveness of the anticlotting medication clopidogrel, and physicians should avoid using this combination of drugs, according to the US Food and Drug Administration (FDA).

Omeprazole inhibits a drug-metabolizing enzyme, CYP2C19, which converts clopidogrel into its active metabolite. Recent studies measuring the blood levels of clopidogrel's active ingredient in patients who took clopidogrel alone or combined with omeprazole found that individuals who took both drugs had 45% lower levels of clopidogrel's metabolite. Additionally, the effect on platelets was reduced by as much as 47% in patients who also took omeprazole. These reductions were seen both when the drugs were taken simultaneously and when they were taken with a 12-hour interval in between.

First Page Preview View Large
First page PDF preview
First page PDF preview
×